Patents by Inventor K. Ulrich Bayer

K. Ulrich Bayer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for CaMKII inhibitors and uses thereof
    Patent number: 10300107
    Abstract: Embodiments herein generally relate to methods, compositions and uses of CaMKII inhibitors. Other embodiments relate to methods, compositions and uses of agents that target CaMKII. Yet further embodiments relate to compositions, methods and uses of CaMKIIN-derived molecules and other CaMKII inhibitor molecules that inhibit autonomous CaMKII activity. In accordance with these embodiments, compositions that inhibit autonomous CaMKII activity may be used for treating conditions causing neuronal cell death, for treating cancer or for treating neurodegenerative disorders.
    Type: Grant
    Filed: September 14, 2017
    Date of Patent: May 28, 2019
    Assignee: THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
    Inventors: K. Ulrich Bayer, Steve Coultrap
  • COMPOSITIONS AND METHODS FOR CaMKII INHIBITORS AND USES THEREOF
    Publication number: 20170368136
    Abstract: Embodiments herein generally relate to methods, compositions and uses of CaMKII inhibitors. Other embodiments relate to methods, compositions and uses of agents that target CaMKII. Yet further embodiments relate to compositions, methods and uses of CaMKIIN-derived molecules and other CaMKII inhibitor molecules that inhibit autonomous CaMKII activity. In accordance with these embodiments, compositions that inhibit autonomous CaMKII activity may be used for treating conditions causing neuronal cell death, for treating cancer or for treating neurodegenerative disorders.
    Type: Application
    Filed: September 14, 2017
    Publication date: December 28, 2017
    Inventors: K. Ulrich BAYER, Steve Coultrap
  • Compositions and methods for CaMKII inhibitors and uses thereof
    Patent number: 9775876
    Abstract: Embodiments herein generally relate to methods, compositions and uses of CaMKII inhibitors. Other embodiments relate to methods, compositions and uses of agents that target CaMKII. Yet further embodiments relate to compositions, methods and uses of CaMKIIN-derived molecules and other CaMKII inhibitor molecules that inhibit autonomous CaMKII activity. In accordance with these embodiments, compositions that inhibit autonomous CaMKII activity may be used for treating conditions causing neuronal cell death, for treating cancer or for treating neurodegenerative disorders.
    Type: Grant
    Filed: September 17, 2015
    Date of Patent: October 3, 2017
    Assignee: THE REGENTS OF THE UNIVERSITY OF COLORADO, a body corporate
    Inventors: K. Ulrich Bayer, Steve Coultrap
  • COMPOSITIONS AND METHODS FOR CaMKII INHIBITORS AND USES THEREOF
    Publication number: 20160008422
    Abstract: Embodiments herein generally relate to methods, compositions and uses of CaMKII inhibitors. Other embodiments relate to methods, compositions and uses of agents that target CaMKII. Yet further embodiments relate to compositions, methods and uses of CaMKIIN-derived molecules and other CaMKII inhibitor molecules that inhibit autonomous CaMKII activity. In accordance with these embodiments, compositions that inhibit autonomous CaMKII activity may be used for treating conditions causing neuronal cell death, for treating cancer or for treating neurodegenerative disorders.
    Type: Application
    Filed: September 17, 2015
    Publication date: January 14, 2016
    Inventors: K. Ulrich BAYER, Steve Coultrap
  • Compositions and methods for CaMKII inhibitors and uses thereof
    Patent number: 8816046
    Abstract: Embodiments herein generally relate to methods, compositions and uses of CaMKII inhibitors. Other embodiments relate to methods, compositions and uses of agents that target CaMKII. Yet further embodiments relate to compositions, methods and uses of CaMKIIN-derived molecules and other CaMKII inhibitor molecules that inhibit autonomous CaMKII activity. In accordance with these embodiments, compositions that inhibit autonomous CaMKII activity may be used for treating conditions causing neuronal cell death, for treating cancer or for treating neurodegenerative disorders.
    Type: Grant
    Filed: September 26, 2008
    Date of Patent: August 26, 2014
    Assignee: The University of Colorado, a body corporate
    Inventor: K. Ulrich Bayer
  • COMPOSITIONS AND METHODS FOR CaMKII INHIBITORS AND USES THEREOF
    Publication number: 20140179613
    Abstract: Embodiments herein generally relate to methods, compositions and uses of CaMKII inhibitors. Other embodiments relate to methods, compositions and uses of agents that target CaMKII. Yet further embodiments relate to compositions, methods and uses of CaMKIIN-derived molecules and other CaMKII inhibitor molecules that inhibit autonomous CaMKII activity. In accordance with these embodiments, compositions that inhibit autonomous CaMKII activity may be used for treating conditions causing neuronal cell death, for treating cancer or for treating neurodegenerative disorders.
    Type: Application
    Filed: February 5, 2014
    Publication date: June 26, 2014
    Inventors: K. Ulrich BAYER, Steve Coultrap
  • Compositions and method for CaMKII inhibitors and uses thereof
    Patent number: 8685926
    Abstract: Embodiments herein generally relate to methods, compositions and uses of CaMKII inhibitors. Other embodiments relate to methods, compositions and uses of agents that target CaMKII. Yet further embodiments relate to compositions, methods and uses of CaMKIIN-derived molecules and other CaMKII inhibitor molecules that inhibit autonomous CaMKII activity. In accordance with these embodiments, compositions that inhibit autonomous CaMKII activity may be used for treating conditions causing neuronal cell death, for treating cancer or for treating neurodegenerative disorders.
    Type: Grant
    Filed: July 12, 2011
    Date of Patent: April 1, 2014
    Assignee: The Regents of the University of Colorado, a body corporate
    Inventors: K. Ulrich Bayer, Steve Coultrap
  • COMPOSITIONS AND METHODS FOR CaMKII INHIBITORS AND USES THEREOF
    Publication number: 20120015885
    Abstract: Embodiments herein generally relate to methods, compositions and uses of CaMKII inhibitors. Other embodiments relate to methods, compositions and uses of agents that target CaMKII. Yet further embodiments relate to compositions, methods and uses of CaMKIIN-derived molecules and other CaMKII inhibitor molecules that inhibit autonomous CaMKII activity. In accordance with these embodiments, compositions that inhibit autonomous CaMKII activity may be used for treating conditions causing neuronal cell death, for treating cancer or for treating neurodegenerative disorders.
    Type: Application
    Filed: July 12, 2011
    Publication date: January 19, 2012
    Inventors: K. Ulrich BAYER, Steve Coultrap
  • COMPOSITIONS AND METHODS FOR CaMKII INHIBITORS AND USES THEREOF
    Publication number: 20100285033
    Abstract: Embodiments herein generally relate to methods, compositions and uses of CaMKII inhibitors. Other embodiments relate to methods, compositions and uses of agents that target CaMKII. Yet further embodiments relate to compositions, methods and uses of CaMKIIN-derived molecules and other CaMKII inhibitor molecules that inhibit autonomous CaMKII activity. In accordance with these embodiments, compositions that inhibit autonomous CaMKII activity may be used for treating conditions causing neuronal cell death, for treating cancer or for treating neurodegenerative disorders.
    Type: Application
    Filed: September 26, 2008
    Publication date: November 11, 2010
    Applicant: REGENTS OF THE UNIVERSITY OF COLORADO
    Inventor: K. Ulrich Bayer